X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
index medicus (27) 27
male (23) 23
middle aged (22) 22
female (19) 19
aged (18) 18
hematology (17) 17
adult (16) 16
chemotherapy (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
aged, 80 and over (12) 12
oncology (12) 12
cancer (11) 11
care and treatment (11) 11
lymphomas (10) 10
treatment outcome (10) 10
elderly-patients (7) 7
neoplasm staging (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
clinical trials (6) 6
medicine, general & internal (6) 6
prognosis (6) 6
rituximab (6) 6
abridged index medicus (5) 5
analysis (5) 5
antineoplastic agents - therapeutic use (5) 5
medicine & public health (5) 5
non-hodgkins-lymphoma (5) 5
survival rate (5) 5
transplantation (5) 5
young adult (5) 5
adolescent (4) 4
aged patients (4) 4
anthracyclines (4) 4
cancer patients (4) 4
cancer therapies (4) 4
disease-free survival (4) 4
drug administration schedule (4) 4
first-line treatment (4) 4
geriatrics (4) 4
hodgkin disease - drug therapy (4) 4
lymphoma (4) 4
lymphoma, large b-cell, diffuse - drug therapy (4) 4
maintenance treatment (4) 4
open-label (4) 4
patients (4) 4
progression-free survival (4) 4
prospective studies (4) 4
quality of life (4) 4
recurrence (4) 4
remission induction (4) 4
survival (4) 4
antimitotic agents (3) 3
antineoplastic agents (3) 3
bendamustine (3) 3
bone-marrow-transplantation (3) 3
clinical medicine (3) 3
clinical-trials (3) 3
combination (3) 3
criteria (3) 3
dlbcl (3) 3
doxorubicin - administration & dosage (3) 3
elderly (3) 3
elderly people (3) 3
geriatric assessment (3) 3
lymphoma, follicular - diagnosis (3) 3
mantle cell lymphoma (3) 3
multiple myeloma (3) 3
non-hodgkin-lymphoma (3) 3
nursing (3) 3
older people (3) 3
patient outcomes (3) 3
phase-2 (3) 3
positron-emission-tomography (3) 3
retrospective studies (3) 3
rituximab - administration & dosage (3) 3
stem cell transplantation (3) 3
therapy (3) 3
time factors (3) 3
tomography, x-ray computed (3) 3
abvd (2) 2
age factors (2) 2
anti-cd20 monoclonal-antibody (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
antibodies, monoclonal, murine-derived - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
autografts (2) 2
bendamustine plus rituximab (2) 2
biopsy (2) 2
bleomycin - administration & dosage (2) 2
breast-cancer (2) 2
carfilzomib (2) 2
chemotherapy plus rituximab (2) 2
clinical trials as topic (2) 2
combined modality therapy (2) 2
comorbidity (2) 2
confidence intervals (2) 2
cyclophosphamide - therapeutic use (2) 2
cytogenetics (2) 2
dacarbazine - administration & dosage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1601 - 1601
Abstract Background: Follicular lymphoma is usually a disase with a prolonged course and a chemotherapy-free regimen might be a favourable treatment strategy.... 
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 487 - 487
Abstract Rationale: Proteasome inhibitor-refractory multiple myeloma (MM) patients are a difficult to treat population with a very poor prognosis. The activity... 
Journal Article
Journal Article
Hematological Oncology, ISSN 0278-0232, 12/2016, Volume 34, Issue 4, pp. 217 - 223
Journal Article
Haematologica, ISSN 0390-6078, 2016, Volume 101, Issue 3, pp. 346 - 355
Journal Article
BLOOD, ISSN 0006-4971, 07/2019, Volume 134, Issue 4, pp. 353 - 362
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2016, Volume 174, Issue 2, pp. 255 - 263
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1099 - 1099
Abstract Background: The randomized phase-2 trial SAKK 35/10 was conducted by the Swiss Group for Clinical Cancer Research (SAKK) and the Nordic Lymphoma Group... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2017, Volume 176, Issue 5, pp. 770 - 782
The combination of lenalidomide (Revlimid super( registered ), R) and dexamethasone (d) is a standard regimen for patients with relapsed/refractory multiple... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 922 - 922
Abstract Introduction. The majority of SMZLs display an indolent course, however the disease is still incurable and a significant proportion of patients... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 3069 - 3069
Abstract Introduction: While R-CHOP has improved survival for DLBCL, outcome in patients (pts) with relapsed/refractory disease remains dismal and may have... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4747 - 4747
Abstract Rationale: Overcoming proteasome inhibitor (PI) resistance is a challenge in multiple myeloma (MM) therapy since most MM patients ultimately develop... 
Journal Article
Journal Article